Haematologica (Aug 2021)
Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
- Samer A. Srour,
- Denái R. Milton,
- Qaiser Bashir,
- Yago Nieto,
- Neeraj Saini,
- May Daher,
- Jeremy Ramdial,
- Jin Im,
- Chitra Hosing,
- Ruby Delgado,
- Elisabet Manasanch,
- Hans C. Lee,
- Sheeba Thomas,
- Greg Kaufman,
- Krina Patel,
- Uday Popat,
- Donna Weber,
- Robert Orlowski,
- Elizabeth Shpall,
- Richard E. Champlin,
- Muzaffar H. Qazilbash
Affiliations
- Samer A. Srour
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Denái R. Milton
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston
- Qaiser Bashir
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Yago Nieto
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Neeraj Saini
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- May Daher
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Jeremy Ramdial
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Jin Im
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Chitra Hosing
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Ruby Delgado
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Elisabet Manasanch
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
- Hans C. Lee
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
- Sheeba Thomas
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
- Greg Kaufman
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
- Krina Patel
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
- Uday Popat
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Donna Weber
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
- Robert Orlowski
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
- Elizabeth Shpall
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Richard E. Champlin
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- Muzaffar H. Qazilbash
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
- DOI
- https://doi.org/10.3324/haematol.2021.279179
- Journal volume & issue
-
Vol. 106,
no. 12
Abstract
No abstracts available.Keywords
